
Sign up to save your podcasts
Or


Do you understand the role of non-targetable driver mutations in the management of acute myeloid leukemia (AML)?
Credit available for this activity expires: 5/1/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/991353?ecd=bdc_podcast_libsyn_mscpedu
Socioeconomic Disparities of Cytomegalovirus Credit available for this activity expires: 4/28/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/991326?ecd=bdc_podcast_libsyn_mscpedu
How can community-based oncologists leverage the newest therapies for patients with heavily relapsed/refractory myeloma? Credit available for this activity expires: 4/25/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/991105?ecd=bdc_podcast_libsyn_mscpedu
Are you up to date on the use of lymphocyte-activation gene 3 (LAG3) inhibitors to treat patients with metastatic melanoma?
Credit available for this activity expires: 04/21/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990930?ecd=bdc_podcast_libsyn_mscpedu
Does vessel wall enhancement on magnetic resonance imaging (MRI) always indicate inflammation? How do you assess for vulnerable plaques? Check out this update on vessel wall MRI. Credit available for this activity expires: 4/17/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990793?ecd=bdc_podcast_libsyn_mscpedu
How do you manage patients with Rett syndrome? Credit available for this activity expires: 4/14/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990712?ecd=bdc_podcast_libsyn_mscpedu
Are you and your patients up to date regarding cytomegalovirus (CMV)? Disease burden, patient screening, and education in a nutshell.
Credit available for this activity expires: 4/12/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990638?ecd=bdc_podcast_libsyn_mscpedu
Did you know studies have shown that noncovalent BTK inhibitors are efficacious in patients with covalent BTK inhibitor-pretreated CLL?
Credit available for this activity expires: 4/12/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990418?ecd=bdc_podcast_libsyn_mscpedu
Did you know that despite treatment, patients with Wilson disease (WD) can experience persistent symptoms, irreversible neurologic deficits, and treatment failure? Credit available for this activity expires: 4/4/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/983037?ecd=bdc_podcast_libsyn_mscpedu
Do you know how to select the optimal treatment for a patient with early breast cancer who is eligible for PARP inhibitor and CDK4/6 inhibitor therapy? Credit available for this activity expires: 3/29/2024 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990176?ecd=bdc_podcast_libsyn_mscpedu
From the publisher's feed

136 Listeners

697 Listeners

499 Listeners

163 Listeners

103 Listeners

893 Listeners

13 Listeners

16 Listeners

291 Listeners

264 Listeners

3,347 Listeners

1,158 Listeners

195 Listeners

93 Listeners

520 Listeners

371 Listeners

171 Listeners

60 Listeners

8 Listeners

430 Listeners